← All trials
NCT06418607
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 23, 2020
- Primary completion
- Jul 13, 2020
- Completion date
- Jul 13, 2020
- First posted
- May 17, 2024
- Last posted
- May 17, 2024
- Enrollment
- 65
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- SanofiLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.